Drug Repurposing for Age-Related Macular Degeneration (AMD) Based on Gene Co-Expression Network Analysis
Journal of Ophthalmic and Optometric Sciences,
Vol. 4 No. 2 (2020),
10 April 2020
,
Page 1-14
https://doi.org/10.22037/joos.v3i3.36781
Abstract
Background: Age-related macular degeneration (AMD) is a lesser-known eye disease in the world that gradually destroys a person’s vision by creating dark spots in the center of vision. Material and Methods: Samples of AMD-related genes were extracted from the NCBI, then the gene expression network (GCN) was extracted. In addition, pathway enrichment analysis was performed to investigate the role of co-expressed genes in AMD. Finally, the drug-gene interaction network was plotted.
Results: The results of this work based on bioinformatics showed that many genes are involved in AMD disease, the most important of which are the genes of TYROBP, LILRB2, LCP2, PTPRC, CFH, SPARC, HTR5A.
Overexpression of these genes can be considered as basic biomarkers for this disease, we separated some of which we had from the gene co-expression network and some from the results of genes ontology (genes that have a P value ≤ 0.05). The most important drugs were isolated from the drug-gene network based on degree, which included 5 drugs including ocriplasmin, collagenase clostridium histolyticum, topiramate, primidone, butalbital.
Conclusion: Among the genes we found, three genes of CFH, TYROBP, SPARC seem to be more important than the others. Among drugs, ocriplasmin, topiramate, primidone can play a more important role based on the degree in the drug-gene network, because all steps are performed with different bioinformatics methods, clinical trials must confirm or reject the results.
Keywords: Age-Related Macular Degeneration; AMD; Co-Expression Network; Drug Repurposing.
- Age-related Macular Degeneration
- AMD
- co-expression network
- Drug repurposing
How to Cite
References
References:
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. The Lancet. 2012;379(9827):1728-38.
Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. New England Journal of Medicine. 2008;358(24):2606-17.
de Jong EK, Geerlings MJ, den Hollander AI. Age-related macular degeneration. Genetics and genomics of eye disease. 2020:155-80.
Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Survey of ophthalmology. 1988;32(6):375-413.
Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic epidemiology. 1999;6(2):125-43.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine. 2006;355(14):1419-31.
Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108(4):697-704.
Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron. 2012;75(1):26-39.
Group A-REDSR. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of ophthalmology. 2001;119(10):1417-36.
Martin DF, Maguire MG, Fine SL, Ying G-s, Jaffe GJ, Grunwald JE, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388-98.
Steinbrook R. The price of sight—ranibizumab, bevacizumab, and the treatment of macular degeneration. New England Journal of Medicine. 2006;355(14):1409-12.
Group MPS. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Archives of Ophthalmology. 1991;109(9):1232-41.
Brunner R, Widder RA, Walter P, Lüke C, Godehardt E, Bartz-Schmidt K-U, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina (Philadelphia, Pa). 2000;20(5):483-91.
Hudson HL, Stulting RD, Heier JS, Lane SS, Chang DF, Singerman LJ, et al. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. American journal of ophthalmology. 2008;146(5):664-73. e1.
Kouhsar M, Azimzadeh Jamalkandi S, Moeini A, Masoudi-Nejad A. Detection of novel biomarkers for early detection of Non-Muscle-Invasive Bladder Cancer using Competing Endogenous RNA network analysis. Scientific Reports 2019 9:1. 2019;9(1):1-15. doi: 10.1038/s41598-019-44944-3.
Mousavian Z, Díaz J, Masoudi-Nejad A. Information theory in systems biology. Part II: protein-protein interaction and signaling networks. Seminars in cell & developmental biology. 2016;51:14-23. doi: 10.1016/J.SEMCDB.2015.12.006.
Mousavian Z, Kavousi K, Masoudi-Nejad A. Information theory in systems biology. Part I: Gene regulatory and metabolic networks. Seminars in Cell and Developmental Biology. 2016;51:3-13. doi: 10.1016/j.semcdb.2015.12.007.
Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. Trader as a new optimization algorithm predicts drug-target interactions efficiently. Scientific Reports 2019 9:1. 2019;9(1):1-14. doi: 10.1038/s41598-019-45814-8.
Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy. Computers in Biology and Medicine. 2019;109:254-62. doi: 10.1016/J.COMPBIOMED.2019.05.006.
Masoudi-Sobhanzadeh Y, Omidi Y, Amanlou M, Masoudi-Nejad A. Drug databases and their contributions to drug repurposing. Genomics. 2020;112(2):1087-95. doi: 10.1016/J.YGENO.2019.06.021.
H L, S N, S H, M T-A, F K, M M-J, et al. High-throughput analysis of the interactions between viral proteins and host cell RNAs. Computers in biology and medicine. 2021;135:104611-. doi: 10.1016/J.COMPBIOMED.2021.104611.
Torkamanian-Afshar M, Lanjanian H, Nematzadeh S, Tabarzad M, Najafi A, Kiani F, et al. RPINBASE: An online toolbox to extract features for predicting RNA-protein interactions. Genomics. 2020;112(3). doi: 10.1016/j.ygeno.2020.02.013.
Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research. 2002;30(1):207-10.
Gao J, Liu RT, Cao S, Cui JZ, Wang A, To E, et al. NLRP3 inflammasome: activation and regulation in age-related macular degeneration. Mediators of inflammation. 2015;2015.
Boyer RS, Moore JS. A fast string searching algorithm. Communications of the ACM. 1977;20(10):762-72.
Adhami M, MotieGhader H, Haghdoost AA, Afshar RM, Sadeghi B. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics. 2020;112(1):135-43.
Motieghader H, Kouhsar M, Najafi A, Sadeghi B, Masoudi-Nejad A. mRNA–miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Molecular BioSystems. 2017;13(10):2168-80.
Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P L, Lotia S, et al. A travel guide to Cytoscape plugins. Nature methods. 2012;9(11):1069-76.
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009;4(1):44-57.
Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, et al. DGIdb: mining the druggable genome. Nature methods. 2013;10(12):1209-10.
Wang J, Zhong J, Chen G, Li M, Wu F-x, Pan Y. ClusterViz: a cytoscape APP for cluster analysis of biological network. IEEE/ACM transactions on computational biology and bioinformatics. 2014;12(4):815-22.
Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ, et al. Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic acids research. 2021;49(D1):D1144-D51.
Kuchroo M, DiStasio M, Calapkulu E, Ige M, Zhang L, Sheth AH, et al. Topological analysis of single-cell data reveals shared glial landscape of macular degeneration and neurodegenerative diseases. bioRxiv. 2021.
Waksmunski AR. From Variants to Pathways: Interrogating the Genetic Architecture of Age-Related Macular Degeneration: Case Western Reserve University; 2020.
Liu B, Sen HN, Nussenblatt R. Susceptibility genes and pharmacogenetics in ocular inflammatory disorders. Ocular immunology and inflammation. 2012;20(5):315-23.
Yan SL-S, Hwang I-Y, Kamenyeva O, Kabat J, Kim JS, Park C, et al. Unrestrained Gαi2 Signaling Disrupts Neutrophil Trafficking, Aging, and Clearance. Frontiers in immunology. 2021;12.
Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115(6):1019-25.
Hiscott P, Howard C, García-Fiñana M, Yan Q. Expression of the Matricellular Protein SPARC in the Human Retinal Pigment Epithelium Changes With Age. Investigative Ophthalmology & Visual Science. 2007;48(13):3012-.
Uehara H, Luo L, Simonis J, Singh N, Taylor EW, Ambati BK. Anti-SPARC oligopeptide inhibits laser-induced CNV in mice. Vision research. 2010;50(7):674-9.
Hagstrom SA, Ying G-s, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, et al. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013;120(3):593-9.
Novack RL, Staurenghi G, Girach A, Narendran N, Tolentino M. Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration. Ophthalmology. 2015;122(4):796-802.
Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, et al. Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surgery, Lasers and Imaging Retina. 2013;44(4):334-43.
Chu P H, Tu H. Methods for treating macular degeneration with topiramate. Google Patents; 2005.
Dehghani A, Abtahi M-A, Abtahi S-H, Peyman A, Etemadifar M, Ghanbari H, et al. Massive bilateral choroidal detachment induced by administration of topiramate. Case reports in ophthalmology. 2011;2(2):251-5.
- Abstract Viewed: 157 times
- pdf Downloaded: 136 times
